Szabolcs Fátrai

2.1k total citations
25 papers, 1.5k citations indexed

About

Szabolcs Fátrai is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Szabolcs Fátrai has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Hematology. Recurrent topics in Szabolcs Fátrai's work include Pancreatic function and diabetes (6 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Szabolcs Fátrai is often cited by papers focused on Pancreatic function and diabetes (6 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Szabolcs Fátrai collaborates with scholars based in Netherlands, United States and Finland. Szabolcs Fátrai's co-authors include Ernesto Bernal‐Mizrachi, Mitsuru Ohsugi, M. Alan Permutt, James D. Johnson, Kenichi Otani, Kenneth S. Polonsky, Zhiqiang Han, Onno Kranenburg, Inne H.M. Borel Rinkes and Norman Balcázar and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Szabolcs Fátrai

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Szabolcs Fátrai Netherlands 17 850 647 291 274 245 25 1.5k
Keishi Yamauchi Japan 21 986 1.2× 415 0.6× 178 0.6× 205 0.7× 173 0.7× 83 1.8k
Axelle Cadoret France 20 1.0k 1.2× 313 0.5× 136 0.5× 165 0.6× 269 1.1× 27 1.7k
Jason Gay United States 18 653 0.8× 203 0.3× 189 0.6× 201 0.7× 440 1.8× 30 1.6k
Lynn Cheatham United States 9 1.6k 1.9× 283 0.4× 273 0.9× 94 0.3× 232 0.9× 16 2.1k
Ercument Dirice United States 25 844 1.0× 822 1.3× 81 0.3× 488 1.8× 125 0.5× 45 1.6k
Yafa Ariav Israel 13 658 0.8× 481 0.7× 447 1.5× 159 0.6× 80 0.3× 13 1.2k
Hugo B. Sanchez United States 10 891 1.0× 838 1.3× 98 0.3× 88 0.3× 240 1.0× 19 1.5k
Rocío Letón Spain 20 457 0.5× 308 0.5× 121 0.4× 299 1.1× 262 1.1× 25 1.3k
Linda Robinson United States 17 802 0.9× 276 0.4× 296 1.0× 100 0.4× 111 0.5× 24 1.4k
Tsugumichi Saito Japan 18 568 0.7× 241 0.4× 164 0.6× 95 0.3× 120 0.5× 69 1.1k

Countries citing papers authored by Szabolcs Fátrai

Since Specialization
Citations

This map shows the geographic impact of Szabolcs Fátrai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szabolcs Fátrai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szabolcs Fátrai more than expected).

Fields of papers citing papers by Szabolcs Fátrai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szabolcs Fátrai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szabolcs Fátrai. The network helps show where Szabolcs Fátrai may publish in the future.

Co-authorship network of co-authors of Szabolcs Fátrai

This figure shows the co-authorship network connecting the top 25 collaborators of Szabolcs Fátrai. A scholar is included among the top collaborators of Szabolcs Fátrai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szabolcs Fátrai. Szabolcs Fátrai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connor, Marie, Ron C.J. Schackmann, Igor Odintsov, et al.. (2024). Abstract 1903: Zenocutuzumab, a HER2xHER3 bispecific antibody, is effective in cancer models with high NRG1 expression. Cancer Research. 84(6_Supplement). 1903–1903. 1 indexed citations
2.
O’Connor, Marie, Alexandre Deshière, Martijn van Rosmalen, et al.. (2022). Abstract 336: Mechanism of action of MCLA-129, a bispecific antibody that targets EGFR and c-MET and impairs growth of EGFR exon 20 insertion mutant non-small cell lung cancer. Cancer Research. 82(12_Supplement). 336–336. 2 indexed citations
3.
Argilés, Guillem, Christiane Jungels, Rocio García‐Carbonero, et al.. (2021). Phase I dose-escalation study of MCLA-158, a first-in-class bispecific antibody targeting EGFR and LGR5, in metastatic colorectal cancer (CRC).. Journal of Clinical Oncology. 39(3_suppl). 62–62. 5 indexed citations
4.
Fátrai, Szabolcs, Paulina M. H. van Strien, Hans W. J. de Looper, et al.. (2020). Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia. Cell Reports Medicine. 1(5). 100074–100074. 14 indexed citations
5.
Borovski, Tijana, Thomas T. Vellinga, Jamila Laoukili, et al.. (2016). Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer. Gut. 66(6). 1106–1115. 24 indexed citations
6.
Vellinga, Thomas T., Inne H. Borel Rinkes, Bas Ponsioen, et al.. (2016). Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion. Oncogene. 35(40). 5263–5271. 89 indexed citations
7.
Vellinga, Thomas T., Tijana Borovski, Vincent C. J. de Boer, et al.. (2015). SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer. Clinical Cancer Research. 21(12). 2870–2879. 165 indexed citations
8.
Fátrai, Szabolcs, Inge Ubink, Klaas M. Govaert, et al.. (2015). Maintenance of Clonogenic KIT+ Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells. Gastroenterology. 149(3). 692–704. 31 indexed citations
9.
Emmink, Benjamin L., Jamila Laoukili, Anna P. Kipp, et al.. (2014). GPx2 Suppression of H2O2 Stress Links the Formation of Differentiated Tumor Mass to Metastatic Capacity in Colorectal Cancer. Cancer Research. 74(22). 6717–6730. 77 indexed citations
10.
Vellinga, Thomas T., Vincent C. J. de Boer, Tijana Borovski, et al.. (2014). Abstract 3351: Survival of colorectal cancer cells following chemotherapy relies on a SIRT1-dependent increase in oxidative phosphorylation. Cancer Research. 74(19_Supplement). 3351–3351. 1 indexed citations
11.
Govaert, Klaas M., Benjamin L. Emmink, Maarten W. Nijkamp, et al.. (2013). Hypoxia After Liver Surgery Imposes an Aggressive Cancer Stem Cell Phenotype on Residual Tumor Cells. Annals of Surgery. 259(4). 750–759. 49 indexed citations
12.
Fátrai, Szabolcs, Albertus T.J. Wierenga, Simon Daenen, Edo Vellenga, & Jan Jacob Schuringa. (2011). Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells. Blood. 117(12). 3320–3330. 47 indexed citations
13.
Fátrai, Szabolcs, Djoke van Gosliga, Lina Han, et al.. (2010). KRASG12V Enhances Proliferation and Initiates Myelomonocytic Differentiation in Human Stem/Progenitor Cells via Intrinsic and Extrinsic Pathways. Journal of Biological Chemistry. 286(8). 6061–6070. 21 indexed citations
14.
Elghazi, Lynda, Norman Balcázar, Manuel Blandino-Rosano, et al.. (2010). Decreased IRS Signaling Impairs β-Cell Cycle Progression and Survival in Transgenic Mice Overexpressing S6K in β-Cells. Diabetes. 59(10). 2390–2399. 55 indexed citations
15.
Fátrai, Szabolcs, Hein Schepers, Henko Tadema, et al.. (2008). Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases. Experimental Hematology. 36(10). 1254–1265. 29 indexed citations
16.
Niiranen, Kirsi, Tuomo A. Keinänen, Eija Pirinen, et al.. (2006). Mice with targeted disruption of spermidine/spermine N1-acetyltransferase gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging. Journal of Cellular and Molecular Medicine. 10(4). 815–827. 3 indexed citations
17.
Niiranen, Kirsi, Tuomo A. Keinänen, Eija Pirinen, et al.. (2006). Mice with targeted disruption of spermidine/spermine N1-acetyltransferase gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging. Journal of Cellular and Molecular Medicine. 10(4). 933–945. 39 indexed citations
18.
Fátrai, Szabolcs, et al.. (2005). Simple PCR heteroduplex, SSCP mutation screening methods for the detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine (CCLM). 43(12). 1346–50. 7 indexed citations
19.
Bernal‐Mizrachi, Ernesto, Mitsuru Ohsugi, J. Wasson, et al.. (2005). Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia. 48(11). 2313–2321. 177 indexed citations
20.
Bernal‐Mizrachi, Ernesto, Szabolcs Fátrai, James D. Johnson, et al.. (2004). Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β cells. Journal of Clinical Investigation. 114(7). 928–936. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026